Products for Research Use Only
RegisterLogin

SX-682

CAT: 0013-GTR19165913-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19165913-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SX-682 is an oral small molecule allosteric inhibitor of the chemokine receptors CXCR1 and CXCR2. By blocking myeloid-derived suppressor cell recruitment, it enhances T-cell activity and anti-tumor immunity, showing therapeutic potential in preclinical models of castration-resistant prostate cancer and other solid tumors.
CAS Number
1648843-04-2
Product Name Alternative
Allosteric, antitumor, cells, CXCR1, CXCR2, CXCR, CXC chemokine receptors, immunity, MDSCs, Inhibitor, inhibit, myeloid-derived, tumor, SX682, SX-682, SX 682, suppressor, recruitment
Field of Research
Immunology & Inflammation
Purity
>98%
Bioactivity
CXCR1/2 inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
C (SC=1N=CC (C (NC2=CC=C (F) C=C2) =O) =CN1) C3=C (B (O) O) C=CC (OC (F) (F) F) =C3
Molecular Formula
C19H14BF4N3O4S
Molecular Weight
467.2
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
[2-[[5-[ (4-Fluorophenyl) carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4- (trifluoromethoxy) phenyl]boronic acid

Chemical Information

(2-((5-((4-Fluorophenyl)carbamoyl)pyrimidin-2-yl)sulfanylmethyl)-4-(trifluoromethoxy)phenyl)boronic acid

SX-682 is under investigation in clinical trial NCT04574583 (Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With Bintrafusp Alfa (M7824 or Tgf-beta "Trap"/pd-l1) With CV301 TRICOM in Advanced Solid Tumors (STAT)).

CAS Number1648843-04-2
PubChem CID90467234
IUPAC Name[2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl]boronic acid
Molecular FormulaC19H14BF4N3O4S
Molecular Weight467.2
Topological Polar Surface Area130
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count7
Heavy Atom Count32
Formal Charge0
Complexity606
SMILES
B(C1=C(C=C(C=C1)OC(F)(F)F)CSC2=NC=C(C=N2)C(=O)NC3=CC=C(C=C3)F)(O)O
InChI
InChI=1S/C19H14BF4N3O4S/c21-13-1-3-14(4-2-13)27-17(28)12-8-25-18(26-9-12)32-10-11-7-15(31-19(22,23)24)5-6-16(11)20(29)30/h1-9,29-30H,10H2,(H,27,28)
InChIKey
SDUDZBCEHIZMFZ-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of (2-((5-((4-Fluorophenyl)carbamoyl)pyrimidin-2-yl)sulfanylmethyl)-4-(trifluoromethoxy)phenyl)boronic acid
CAS: 1648843-04-2
CID: 90467234
Formula: C19H14BF4N3O4S
MW: 467.2
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight467.2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count7
Exact Mass467.0734199
Monoisotopic Mass467.0734199
Topological Polar Surface Area130 Ų
Heavy Atom Count32
Formal Charge0
Complexity606
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19208233-01SX-576
GTR19196392-01SX-517
GTR19200789-01SX 011
GTR19204709-01SX-3228
GTR19209497-01SX 3202
GTR19188477-01RK-682 (+/-)
GTR19209547-01RK-682
GTR19276572-01CRBN ligand-682
GTR18904097-01SRC-1 (682-697)
GTR19066981-01SRC - 1 (682–697)

Alternative Products

CatalogName
YQC84304-01SX-682
A22219-100SX-682 100mg
A22219-1SX-682 1mg
A22219-25SX-682 25mg
A22219-5SX-682 5mg
A22219-50SX-682 50mg
A22219-10SX-682 10mg
TBI4925-5MGSX-682, CXCR1/2 inhibitor

Popular Products